Dr. ANDAC SALMAN

Education

• 2014Marmara University Faculty of Medicine, Department of Skin and Venereal Diseases
• 2013Clinical Observer, Dermatology Clinic, Dermato-Allergy Unit, Universitat Autònoma de Barcelona, ​​Hospital del Mar, Spain
• 2009Istanbul University Istanbul Faculty of Medicine
• 2007Maastricht University, Faculty of Health, Medicine and Life Sciences, Hollanda

Experience

• 2022Acıbadem Health Group
• 2020 – 2022Marmara University Faculty of Medicine / Department of Skin and Venereal Diseases / Associate Professor
• 2017 – 2020Marmara University Faculty of Medicine / Department of Skin and Venereal Diseases / Assistant Professor / Assistant Professor
• 2016 – 2017Kirklareli State Hospital / Specialist Doctor
• 2014 – 2016Marmara University Pendik Training and Research Hospital / Department of Skin and Venereal Diseases / Specialist Doctor

Memberships

• Urticaria Centers of Reference and Excellence
• Turkish Pediatric Dermatology Association
• European Academy of Dermatology and Venereology-EADV
• Turkish Dermatology Association
• IDS (International Dermoscopy Society)
• Dermatoimmunology and Allergy Association
• Dermatology and Venereal Diseases Association

PUBLICATIONS

• Real-life Effectiveness and Safety of Dupilumab in Adult Patients with Moderate-to-Severe Atopic DermatitisDermatol Ther. 2022;35:e15192. Salman A, Apti Sengun O, Aktas M, Taskapan O.
• The global impact of the COVID-19 pandemic on the management and course of chronic urticariaAllergy. 2021 Mar;76(3):816-830. doi: 10.1111/all.14687. Kocatürk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J, Comert-Ozer E, ?, Maurer M
• Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: A retrospective cohort studyJ Dermatol Treat. 2020;31:204-209. doi: 10.1080/09546634.2019.1589639. Salman A, Ergun T, Gimenez-Arnau AM.
• Targeted Therapy for Chronic Spontaneous Urticaria- Rationale and Recent ProgressDrugs. 2020;80:1617-1634. Doi: 10.1007/s40265-020-01387-9. Gimenez-Arnau AM, Salman A.
• Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test.Pediatr Dermatol. 2019;36:514-6. doi: 10.1111/pde.13838. Salman A, Yucelten D, Akin Cakici O, Kepenekli Kadayifci E.
• Slime”: A trending cause of isothiazolinone contact allergy in childrenContact Dermatitis. 2019;80:409-11. two: 10.1111/cod.13237. Salman A, Demir G, Apti O.
• The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous UrticariaJ Cutan Med Surg, 2019;23:496-500. two: 10.1177/1203475419847956. Salman A, Commerce E.
• Impact of psoriasis on quality-of-life in children, adolescents and their families: a cross-sectional studyAn Bras Dermatol. 2018;93:819-23. doi: 10.1590/abd1806-4841.20186981. Salman A, Yucelten AD, Sarac E, Saricam MH, Perdahli Fis N.
• Social anxiety and quality of life in vitiligo and acne patients with facial involvement: a cross-sectional, controlled studyAm J Clin Dermatol. 2016;17:305-11. doi: 10.1007/s40257-016-0172-x. Salman A, Kurt E, Topcuoglu V, Demircay Z.
• Panniculitis in juvenile dermatomyositis: report of a case and review of the published workJ Dermatol. 2016;43:951-3. doi: 10.1111/1346-8138.13335. Salman A, Kasapcopur O, Ergun T, Durmus Ucar AN, Demirkesen C.